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Available online 28 September 2014Abstract Adipose tissue-derived stromal cells (ASC) form a rich source of autologous cells for use in regenerative
medicine. In vitro induction of an endothelial phenotype may improve performance of ASCs in cardiovascular repair.
Here, we report on an in vitro strategy using direct reprogramming of ASCs by means of ectopic expression of the
endothelial-specific transcription factor SRY (sex determining region Y)-box18 (SOX18). SOX18 induces ASCs to express
a set of genes involved in vascular patterning: MMP7, KDR, EFNB2, SEMA3G and CXCR4. Accordingly, SOX18 transduced
ASCs reorganize under conditions of shear stress, display VEGF-induced chemotaxis and form tubular structures in 3D
matrices in an MMP7-dependent manner. These in vitro findings provide insight into molecular and cellular processes
downstream of SOX18 and show that reprogramming using SOX18 is sufficient to induce several endothelial-like features
in ASCs.
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Adipose tissue-derived stromal cells (ASCs) have been report-
ed to diverge under specific culture conditions towards
adipogenic, chondrogenic, myogenic and osteogenic cells
(Zuk et al., 2001). This apparent plasticity, combined with
the fact that these cells can be isolated in high numbers by
minimally invasive methods, raised great interest in ASCs as a
source of autologous cells for use in regenerative medicine.
The use of ASCs in cardiovascular repair has been the subject
of several in vitro- and animal studies and has moved towards
clinical applications. Administration of adipose-derived cells,
either freshly isolated or after conditioning in cell culture, was
shown to improve left ventricular function in models of acute
and chronic myocardial infarction. Likewise, in animal models
of hind limb ischemia, favorable effects on revascularization
have been reported (reviewed by Madonna et al. (2009)).
The mechanisms through which ASCs exert these effects are
not fully elucidated. ASCs have been reported to differentiate
both in vitro and in vivo towards cardiomyocytic or endothelial
phenotypes. In animal models it was observed that at least a
part of the administered ASCs actually displays cardiomyocytic
or endothelial markers and becomes structurally incorpo-
rated in the myocardium or vascular structures, respective-
ly (Miranville et al., 2004; Planat-Benard et al., 2004;
Yamada et al., 2006; Miyahara et al., 2006). In addition, it
was shown that ASCs can function as a paracrine source of
growth factors, cytokines and signaling molecules (Miyahara
et al., 2006; Kondo et al., 2009). Thus, the view has emerged
that ASCs support cardiovascular repair by providing local
signals for cell recruitment and tissue survival as well as by
physically substituting, in an adaptive manner, for lost cells.
Several papers describe attempts to specifically differ-
entiate ASCs towards an endothelial phenotype (Miranville
et al., 2004; Planat-Benard et al., 2004; Wosnitza et al.,
2007; Kang et al., 2010; Konno et al., 2010). In vitro culture
of ASCs in media supplemented with specific growth factors,
in particular VEGF and bFGF, resulted in the expression of a
limited range of endothelial markers, mostly with incom-
plete penetrance. In culture, cells did not display the typical
endothelial morphology, nor did they organize in endothelial
sheet-like structures. Therefore, the concept of conditioning
ASCs to cells with an endothelial phenotype by stimulation
with growth factors has proven partially successful but seems
to require further optimization.
Sry-related high-mobility-group box (SOX) transcription
factors are involved in maintaining stemness, differentiation
and lineage commitment. Development of the vasculature
is critically dependent on the SOXF subfamily, consisting of
SOX7, SOX17 and SOX18 (Lefebvre et al., 2007; François et
al., 2010). During mouse embryonic development, SOX18
is expressed in the developing cardiovascular system: in the
allantois and yolk sac blood islands, in the developing heart
and in the paired dorsal aorta. Expression is continued at
sites of embryonal angiogenic- and vasculogenic expansion
and was reported to re-occur in adult skin wounding (Pennisi
et al., 2000a; Darby et al., 2001). In animal models, SOX7,
SOX17 and SOX18 were found to have essential, partly
redundant, roles in the formation of the vasculature during
embryonic development (Pennisi et al., 2000b; François
et al., 2008; Sakamoto et al., 2007; Herpers et al., 2008;
Pendeville et al., 2008; Cermenati et al., 2008; Matsui et al.,2006; Sacilotto et al., 2013). However, their effects at the
level of gene regulation and, thus, the molecular basis of
their role in development are poorly understood. Applying
overexpression and silencing of SOX18 in endothelial cells,
our group has shown that SOX18 has a crucial role in both
the transcription of the endothelial-specific tight junction
protein claudin 5 and maintenance of the endothelial barrier
(Fontijn et al., 2008). Recently, Hoeth et al. (2012) analyzed
the transcriptome of endothelial cells overexpressing SOX18,
pointing at a role for SOX18 in the morphogenesis of the
vasculature. Using defined in vitro culture methods, two
populations of angiogenic cells can be isolated from blood:
early EPCs that contribute to vessel repair in a paracrine
manner and endothelial colony forming cells (ECFCs), or
outgrowth endothelial cells (OEC, late EPC), that have the
capacity to physically form neo-vessels (reviewed in Favre et
al., 2013). Using comparative genome-wide transcriptional
profiling of these two cell populations, Medina et al. (2010)
have shown that the mRNA fingerprint of ECFC closely
resembles that of endothelial cells, and is accompanied
by high, specific expression of SOX18. Thus, the available
literature indicates a key role for SOX18 in vascular develop-
ment and repair, in both embryonic and adult stages, and
in specification of the endothelial phenotype. We therefore
hypothesized that ectopic expression of SOX18 in ASCs might
induce endothelial-like features and tested this reprogram-
ming approach in vitro.
Materials and methods
Isolation of the stromal fraction of adipose tissue
Human subcutaneous adipose tissue samples from elective
plastic surgery were obtained from the department of
Plastic Surgery (Tergooi Hospital in Hilversum, TheNetherlands)
according to hospital guidelines afterwritten informed consent.
Adipose tissue was harvested from the abdomen after resec-
tion. In this study 7 female donors (age range: 40–61 years,
mean: 47 years) were included. Procedures complied with
the principles of the Declaration of Helsinki. After surgery,
adipose tissue was stored in sterile phosphate-buffered saline
(PBS) (B. Braun, Melsungen, Germany) at 4 °C overnight and
processed within 24 h, as described previously (Naaijkens et
al., 2010).
ASC culture and shear stress
ASCs were initially cultured in Dulbecco's modified Eagle's
medium (DMEM) (Gibco) supplemented with 5% platelet
lysate, 100 U/ml penicillin, 100 μg/ml streptomycin (Gibco)
and 10 U/ml heparin (Leo Pharma, Amsterdam). In all
experiments, early passages ASCs (p2–3) were used (Naaijkens
et al., 2010).
Preceding SOX18 transduction, cells were cultured for
10 days on surfaces coated with collagen IV (Sigma Aldrich,
St. Louis, MO, USA) in endothelial cell growth medium
(EGM2) (Lonza, Walkersville, MD, USA) with a final concen-
tration of 10 ng/ml (w/v) basic fibroblast growth factor
(bFGF) (Tebu-Bio, Heerhugowaard, The Netherlands). Cells
were exposed to laminar shear stress as previously described
(Dekker et al., 2002), with the following modifications: cells
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0.6 luer (Ibidi, Martinsried, Germany)) coated with collagen
IV and exposed to a calibrated mean shear stress level of
18 dyn/cm2 for 5 days in EGM2 plus bFGF.
Lentiviral SOX18 transduction
The entire human SOX18 open reading frame (ORF) cDNA was
cloned and expressed from the pRRL-cPPT-CMV-X2-PRE-
SIN-IRES-eGFP vector (kindly provided by Dr. J. Seppen,
Department of Experimental Hepatology, Academic Medical
Center, Amsterdam, The Netherlands) as described previ-
ously (Fontijn et al., 2008). The resulting vector (further
designated as SOX18) carried the CMV promoter followed by
the SOX18 open reading frame, an internal ribosome entry
site (IRES) and a green fluorescent protein (GFP) encoding
sequence. As a control (further designated as mock), the
same vector without SOX18 ORF was used. Lentiviruses were
generated in HEK293T cells as described (Fontijn et al., 2008)
using the CalPhos mammalian transfection kit (Clontech, Palo
Alto, CA). ASCs were grown in EGM2 plus bFGF for 10 days.
Subsequently, cells were replated and transduced at 80%
confluency with SOX18- or mock virus in EGM2 plus bFGF
medium for 24 h after which the cells were used for further
experimentation.
Nuclear extraction and Western blot
Cytoplasmic and nuclear extracts of SOX18 transduced ASCs
were prepared using the NucBuster protein extraction kit
(Merck, Darmstadt, Germany) according to the manufacturer's
instructions. Protein contentwas determined using BCA reagent
(Pierce, Rockford, IL, USA). Samples were denatured by
boiling in sample buffer in the presence of 1% (w/v) SDS.
Equal amounts of protein were separated on 10% SDS-PAGE
followed by transfer to nitrocellulose for immuno-blot
analysis. Blots were blocked in a 1:1 (v/v) dilution of
Odyssey blocking buffer (LI-COR Biosciences, Lincoln, NE,
USA) and PBS. Incubations with primary and secondary
antibodies were performed in a 1:1 (v/v) dilution of Odyssey
blocking reagent and PBS containing 0.1% (v/v) Tween-20.
After each incubation step, blots were washed 3 times for
5 min in PBS containing 0.1% (v/v) Tween-20. Primary
antibody: anti-human SOX18 (Santa Cruz, CA, USA) dilution
1:200, incubation 4 °C overnight, secondary antibody: anti-
rabbit IRDye 800 (LI-COR Biosciences) dilution 1:10,000,
incubation 1 h at room temperature. Signals were recorded
and quantified using an Odyssey infrared imaging system
and Odyssey application software (LI-COR).
Immunofluorescence microscopy
ASCs were grown on collagen IV coated coverslips. Cells
were washed with serum-free medium at 37 °C and fixed
for 15 min with 4% paraformaldehyde. Phosphate buffered
saline supplemented with 0.2% gelatin and 0.5% bovine
serum albumin (BSA) was used as a blocking step and during
incubations with primary and secondary antibodies. All
incubations were performed for 1 h at room temperature.
After each incubation step, coverslips were washed 4 times
for 5 min with PBS. Antibodies were diluted according to themanufacturer's instructions. Primary antibody: anti-human
SOX18 (Santa Cruz, CA, USA), secondary antibody: anti-
rabbit Alexa Fluor 555 (Molecular Probes Eugene, OR, USA).
Coverslips were mounted in Mowiol (Calbiochem, La Jolla,
CA) and images were recorded using a Leica DM6000
microscope and Leica Application Suite software (Leica
Microsystems, Wetzlar, Germany).
Real-time reverse transcription-polymerase chain
reaction (RT-PCR)
Total RNA was isolated using the Aurum total RNA mini kit
(Bio-Rad, Veenendaal, The Netherlands) according to the
manufacturer's instructions. 0.5 μg of total RNA was used for
reverse transcription, with a (dT)12–18 primer using Super-
script II (Invitrogen), according to the manufacturer's instruc-
tions. PCR reactions were performed in 10 μl volumes using
Fast SYBR Green Master Mix (Applied Biosystems, Bleiswijk,
The Netherlands) on a 7900HT Fast Real-Time PCR system
(Applied Biosystems). Specificity of the amplification was
checked by melt curve analysis. P0 levels were used for
normalization. Primer sequences are given in Supplementary
Table 1.
Flow cytometry
ASCs were detached by brief trypsinization followed by
washing steps with medium and PBS containing 0.5% bovine
serum albumin (BSA). Cells were incubated for 45 min with
APC- or PE-labeled antibodies against KDR (VEGFR2) (Miltenyi
Biotec, Leiden, The Netherlands) and CD34 (BioLegend San
Diego, CA, USA). Cells were washed and surface expression
was analyzed using a FACSCalibur (Becton Dickinson, San Jose,
CA, USA).
In vitro angiogenesis model
3D human fibrin matrices were prepared by the addition of
thrombin (0.05 U/ml) to a solution of 2 mg/ml fibrinogen
(Kordia, Leiden, The Netherlands) in M199 medium. 100 μl
was added to the wells of a 96-well plate. For network
formation and subsequent polymerization, plates were incu-
bated for one hour at room temperature followed by one
hour at 37 °C. Thrombin was inactivated by the addition
of medium; M199 (Gibco) containing 100 U/ml penicillin,
100 μg/ml streptomycin (Gibco), 10% human serum and 10%
new born calf serum. Transduced ASCs were seeded at a
density of 18.103 cells per well. After adherence of the cells
overnight themediumwas changed and, eventually, inhibitors
were added. The experiments were terminated by washing in
M199 and fixation with 2% paraformaldehyde for two hours.
Tubular structures were recorded and quantified as described
previously (Koolwijk et al., 1996). Matrices were embedded
in paraffin and immunohistochemistry was performed as
described previously (Naaijkens et al., 2010).
Chemotaxis
ASC chemotaxis was performed using fibronectin-coated
8 μm pore size Transwell inserts (Corning Inc. Life Sciences,
Figure 1 Nuclear localization of SOX18 in ASCs. ASCs were
grown and transduced with mock or SOX18 lentivirus as
described in Materials and methods. Five days after transduc-
tion, cells were analyzed for SOX18 subcellular localization by
cell fractionation and immunofluorescence. (A) Cell fraction-
ation. SOX18 distribution between cytoplasm and nucleoplasm
was analyzed by SDS-PAGE and Western blotting. Lanes were
loaded with 15 μg total protein. Detection was performed using
antibodies raised against SOX18. (B) Immunofluorescent local-
ization of SOX18. ASCs were grown on coverslips coated with
collagen IV and transduced. After paraformaldehyde fixation,
SOX18 localization was determined using an antibody raised
against SOX18 (red). Nuclei were stained with Hoechst 33342
(blue). Bars: 25 μm.
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resuspended in EGM2 without VEGF and seeded at a density
of 15.103 cells per filter (0.33 cm2). Cells were allowed to
adhere for at least six hours after which the medium was
changed to EBM2 (Lonza) supplemented with 0.5% HSA
(Sanquin, Amsterdam, The Netherlands). VEGF was added
to the lower compartment at a concentration of 25 ng/ml
and cells were allowed to transmigrate for 16 h. Membranes
were fixed in 4% PFA for 30 min and non-migrated cells
were removed from the upper side of the membrane using
cottonwool tips. Cells at the lower side of the filter were
stained with Hoechst 33342. Transduced (GFP-positive) cells
were quantified by counting 3 times 5 fields at 200×
magnification using an inverted microscope.
Statistical analysis
Data are reported as mean and standard deviation (SD).
Differences in mean values were analyzed using Student's
t-test. Differences were considered significant at the p b 0.05
level.
Results
SOX18 shows nuclear localization upon transduction
in ASCs
Early passage (p2–3) ASCs were grown on collagen IV matrices
in EGM2 medium supplemented with bFGF, to provide con-
ditions that were shown to enhance expression of endothelial
features (Konno et al., 2010). We then sought to further
improve this approach by combining these growth conditions
with reprogramming of the cells by ectopic expression of the
endothelial-specific transcription factor SOX18. SOX18 was
transduced using a lentiviral vector containing the human
SOX18 open reading frame (ORF) linked to an internal ribosome
entry site (IRES) and a sequence encoding green fluorescent
protein (GFP). Five days after transduction, monitoring of GFP
expression revealed transduction efficiencies of N50%. Previ-
ously, we have shown cell type-specific expression of SOX18
in confluent endothelial cells, with a predominant nuclear
localization of both endogenous and lentivirally-overexpressed
SOX18 (Fontijn et al., 2008). Consistent with these earlier
findings, SOX18 expressed in ASCs showed a major band of
slightly less than 50 kDa on Western blot (Fig. 1a). Quantitative
comparison of SOX18 protein in equal protein weight samples of
cytoplasm and nucleoplasm revealed a 3.1-fold enrichment in
the nucleus. This prevailing nuclear localization was confirmed
by immunofluorescence microscopy (Fig. 1b).
SOX18 transduction in ASCs induces expression of
(precursor) endothelial genes
After having established correct nuclear localization of SOX18
in heterologous ASCs, we determined the effects of SOX18
transduction on expression levels of a set of prototypical
endothelial-specific genes. Cells were grown on collagen IV
matrices in EGM2 medium supplemented with bFGF. Five days
after SOX18 transduction, RNA was harvested from ASCs and
mRNA levels of CDH5 (VE-Cadherin), PECAM1 (CD31), TEK(TIE2), vWF (von Willebrand factor), CD34, KDR (VEGFR2) and
CLDN5 (claudin 5) were determined by semi-quantitative
RT-PCR. vWF mRNA was not detected (data not shown). For
CDH5, PECAM1, TIE2 and CLDN5, we observed a tendency
towards an increase in expression, surpassing that of growth
medium alone, upon transduction with SOX18 (Fig. 2a).
However, with the exception of CLDN5, none of these genes
reached significant levels of additional induction due to a
considerable variation in response to SOX18 expression which
is likely to reflect isolate- and transduction-dependent hetero-
geneity of the ASC cultures. Both basal- and SOX18-induced
expression levels of all genes examined remained low as
compared to primary endothelial cells (0.4% and less). Using
immunofluorescence microscopy we observed expression of
PECAM1 and VE-Cadherin in a limited number of SOX18-
transduced cells whereas expression was not observed in
mock-transduced controls. Both proteins displayed correct
preferential targeting to the lateral membrane (Fig. 2b). In
contrast to the aforementioned endothelial marker genes, KDR
Figure 2 Effects of SOX18 transduction on expression of endothelial markers in ASCs. ASCs were grown and transduced with mock
or SOX18 lentivirus as described in Materials and methods. Five days after transduction, cells were analyzed for expression of
endothelial markers using semi-quantitative RT-PCR, immunofluorescence or flow cytometry. (A) mRNA levels of CHD5, PECAM, TIE2
and CLDN5 in SOX18- and mock-transduced ASCs relative to a pool of two isolates of human umbilical vein endothelial cells (HUVEC).
Data are represented as mean and SD of 3 ASC isolates (**p b 0.01). (B) Immunofluorescent detection of PECAM and VE-Cadherin (both
red). Transduced cells show GFP expression (green). Nuclei were stained with Hoechst 33342 (blue). Bars: 50 μm (PECAM) and 25 μm
(VE-Cadherin). Arrows indicate PECAM1- or VE-Cadherin positive cell–cell contacts. (C) mRNA levels of KDR and CD34 in SOX18- and
mock-transduced ASCs relative to HUVEC. Data are represented as mean and SD of at least 3 ASC isolates (*p b 0.05, **p b 0.01).
(D) Flow cytometric quantification of KDR and CD34 expression in SOX18- and mock-transduced ASCs. GFP+ cells were gated and the
fraction of cells expressing KDR or CD34 was determined. Data are represented as mean and SD of 4 ASC isolates (**p b 0.01).
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ASCs were transduced with SOX18. The resulting expression
levels approached levels measured in primary endothelial cells
(Fig. 2c). FACS analyses confirmed KDR and CD34 positivity of
GFP-gated populations (Fig. 2d).
SOX18 transduction in ASCs induces expression of
morphogenic genes and affects chemotaxis
SOX18 target genes in endothelial cells included the matrix
metalloprotease MMP7 and genes encoding molecules in-
volved in vascular patterning (EFNB2), cellular guidance
(SEMA3G) and chemoattraction (CXCR4) (Hoeth et al., 2012).
Using semi-quantitative QPCR we observed that also in
heterologous ASCs, SOX18 overexpression resulted in signif-
icantly increased levels of these genes (Figs. 3a, b). A major
driving force in vascular morphogenesis is VEGF (Carmeliet
et al., 1996), and we observed a marked induction of KDR
(Figs. 2c, d). VEGF responsiveness would be a hallmark for
the acquisition of endothelial functional properties by ASCs
upon SOX18 transduction. We tested transmigration of SOX18
transduced ASCs through an 8 μM pore size fibronectin-coated
Transwell membrane towards a VEGF gradient. Both SOX18
transduction and addition of VEGF tended to increase
chemotaxis of mock-transduced cells but in both cases
this did not reach significant levels (Fig. 3C). However, SOX18-
transduced cells showed a significant 3.6-fold increase in
VEGF-induced chemotaxis as compared to that in mock-transduced cells. These findings provide evidence that ectopic
SOX18 expression in ASCs induces functional signaling in
response to VEGF.SOX18 transduction in ASCs induces morphologic
changes, alters cell–cell and cell–matrix interactions
and induces responsiveness to shear stress
When cultured under conditions that allow optimal prolifera-
tion, ASCs display an elongated, fibroblast-like spindle shape
(Alt et al., 2011). In contrast, proliferating endothelial cells
under static culture conditions tend to spread, flatten and,
when grown to confluency, adopt a characteristic cobble-stone
morphology. Here, we observed that growth of ASCs in
EGM2 with bFGF medium aggravated the elongated cell
shape as compared to growth in proliferation medium.
Upon transduction with SOX18, ASCs showed spreading and
flattening, resulting in a morphology reminiscent of endothe-
lial cells (Fig. 4A). Shear forces are required for stabilization
and patterning of blood vessels and, in adult life, maintain
vascular homeostasis and drive arteriogenesis in collateral
formation (Eitenmüller et al., 2006). During mouse embryonic
development, SOX18 expression spatiotemporally coincides
with the onset of circulation at 8 post coïtum (Pennisi et al.,
2000a). Therefore, we tested the effects of SOX18 overex-
pression on shear-responsiveness of ASCs by exposing the cells
to flow in a parallel plate chamber. We observed a striking
Figure 3 Effects of SOX18 transduction on expression of vascular patterning genes in ADCs and chemotaxis of ASCs. ASCs were
grown and transduced with mock or SOX18 lentivirus as described in Materials and methods. Five days after transduction, cells were
analyzed for expression of morphogenic genes and VEGF-induced chemotaxis. (A) Semi-quantitative RT-PCR for MMP7 and SEMA3G;
mRNA levels in SOX18- and mock-transduced ASCs relative to HUVEC. (B) Semi-quantitative RT-PCR for EFNB2 and CXCR4; mRNA levels
in SOX18- and mock-transduced ASCs relative to HUVEC. Data are represented as mean and SD of 5 ASC isolates. (**p b 0.01).
(C) VEGF-driven chemotaxis measured as transmigration of SOX18- and mock-transduced ASCs across an 8 μm pore size Transwell filter
coated with fibronectin. Cells were allowed to transmigrate against 25 ng/ml VEGF for 12 h after which filters were fixed and stained
with Hoechst 33342. The number of spread GFP+ cells at the bottom of the membranewas determined. Stimulation of transmigration was
calculated relative to mock transduced cells. Results are represented as mean and SD of three isolates (*p b 0.05, **p b 0.01).
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regard to their morphology and organization when exposed
to prolonged laminar shear stress (5 days at an average of
18 dyn/cm2). Whereas mock-transduced cells were dispersed
throughout the matrix in a random orientation, SOX18-
transduced cells were oriented parallel to the flow vector
and formed elongated clusters (Fig. 4B), indicating that SOX18
expression contributes to plasticity of the cells by weakening
cell–matrix interaction and enhancing cell–cell interaction.
However, combination of overexpression of SOX18 with either
shear stress or with overexpression of a major effector of
shear stress in endothelial cells, the transcription factor KLF2
(Dekker et al., 2002, 2006; Boon & Horrevoets, 2009), had
little effect on expression of genes described in the previous
paragraphs, with the exception of TIE2 (Supplementary Fig.
Fig. a). Only a partial shear responsiveness was thus observed,
possibly due to differences in expression levels of components
of the presumptive shear sensing complex, consisting of
PECAM1, VE-Cadherin and KDR (Tzima et al., 2005) in
SOX-transduced ASCs as compared to endothelial cells
(Fig. 2a–d, Supplementary Fig. Fig. a). Integrins are known to
be involved in endothelial shear responsiveness (Tzima et al.,
2005). We observed that among the integrins tested, only
integrin alphaV (ITGAV), known to be associated with angio-
genesis and cell mobility, is increased upon overexpression of
SOX18 (Fig. 4C). This finding is consistent with the observed
VEGF-induced chemotaxis (Fig. 3C) and suggests increasedplasticity of the SOX18-transduced ASCs under appropriate
stimulatory conditions.SOX18 transduced ASCs show spontaneous formation
of tubular structures in 3D matrices
Next, we tested the behavior of SOX18 transduced ASCs in an
in vitro model of sprouting tubes. SOX18 transduced ASCs
were seeded and grown on three-dimensional matrices of
fibrin as described in Materials and methods. 48 h after
seeding, we observed spontaneous formation of branching
tube-like structures in matrices seeded with SOX18-transduced
ASCs while these structures were virtually absent in matrices
seeded with mock-transduced cells (Fig. 5A). In contrast to
what was previously observed in human microvascular endo-
thelial cells (Koolwijk et al., 1996), the addition of combina-
tions of TNF-α and bFGF or VEGF reduced rather than enhanced
this tube formation (Supplementary Fig. Fig. b). Next, we
performed morphological characterization of the tube-like
structures. Differential interference contrast (DIC) microscopy
was combined with detection of GFP that is co-expressed with
SOX18 in transduced cells. Branched structures, consisting of
multiple GFP-positive cells were found to enter thematrix up to
a depth of approximately 250 μm (Fig. 5B). Using immunohis-
tochemistry, expression of the SOX18 downstream markers
CD34 and KDR was detected on sections of structures formed
Figure 4 Effects of SOX18 transduction on ASC morphology, organization under shear stress and integrin subunit expression. ASCs
were grown and transduced with mock or SOX18 lentivirus as described in Materials and methods. (A) Five days after transduction,
cells were examined using phase contrast and immunofluorescence microscopy. Upper panel from left to right: mock transduced
cells, static growth, phase contrast and corresponding GFP view. Lower panel from left to right: SOX18 transduced cells, static
growth, phase contrast and corresponding GFP view. Bars: 25 μm. (B) After transduction, cells were seeded in a parallel plate-type
flow chamber and exposed to five days of laminar shear stress at an average of 18 dyn cm−2. The direction of laminar shear stress is
indicated with an arrow. Shown is a projection of 20 confocal sections taken every 1.5 μm. Bars: 100 μm. (C) Five days after
transduction, cells were analyzed for expression of mRNA encoding integrin (ITG) subunits using semi-quantitative RT-PCR. mRNA
levels of ITGAV, ITGA2b, ITGB3, ITGB5 and ITGB1 in SOX18- and mock-transduced ASCs were determined relative to HUVEC. Data are
represented as mean and SD of 3 ASC isolates (**p b 0.01).
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chemistry and electron microscopy revealed extensive vacuo-
lation associated specifically with structures formed in the
matrix by SOX18 transduced cells, indicating active lumen
formation being initiated by SOX18 (Fig. 5D).
SOX18-induced formation of tubular structures is
dependent on MMP-7 activity and independent of
VEGF
Since angiogenesis in vivo may occur in matrices of different
compositions, we tested the ability of SOX18 transduced
ASCs to form tubes in matrices composed of fibrin, collagen
and mixtures of 10% collagen and 90% fibrin. In all cases
SOX18 transduction enhanced formation of tubular structures
by ASCs (Supplementary Fig. Fig. c). We then examined the
contribution of two SOX18-induced genes, MMP7 and KDR, to
the formation of tube-like structures by SOX18 transduced
ASC. We quantified structures formed in the presence of the
broad matrix metalloproteinase inhibitor Batimastat or in the
presence of the VEGF inhibitor Avastin/Bevacizumab. As
shown in Fig. 6A, inhibition of MMP activity significantly
decreased formation of tubular structures whereas VEGF
inhibition did not have a significant effect (Fig. 6B). Consistent
with the latter observation, we found in an independent
experiment that neither in the presence nor in the absence ofVEGF, does Avastin or the KDR-kinase inhibitor SU1498 affect
tube formation. The addition of an inhibitor of CXCR4
signaling, AMD3100/Plerixafor, did not affect tube formation
either. Consistent with earlier findings in microvascular
endothelial cells (Koolwijk et al., 1996), aprotinin/Trasylol
significantly reduced tube formation, suggesting the involve-
ment of plasminogen activation in tube formation by SOX18
transduced ASCs (Supplementary Fig. Fig. d). In view of the
effect of Batimastat, we examined the possible induction of
several MMPs in addition to the patterning MMP7. In contrast
to MMP7 (Fig. 3A), none of the MMPs involved in endothelial
sprouting: MMP1, MMP2, MMP3, MMP9, MMP12, and MMP14,
showed significant induction of gene expression in response to
SOX18 (Supplementary Fig. Fig. e). This makes MMP7 the most
likely target for inhibition by Batimastat and suggests a crucial
involvement of MMP7 in the process of tube formation by
SOX18-transduced ASCs.Discussion
Strategies aiming at controlled divergence of ASCs to specific
differentiated cell types essentially rely on prolonged culture
in the presence of specific sets of growth factors and/or
matrix proteins (Zuk et al., 2001). Specific culture conditions
were reported to induce subpopulations of ASCs to express
Figure 5 Tubular structures formed in 3D matrices by SOX18-transduced ASCs. ASCs were grown and transduced with mock or
SOX18 lentivirus as described in Materials and methods. One day after transduction, cells were seeded on matrices and grown as
described in Materials and methods. After 2 days the matrices were fixed with 2% paraformaldehyde. (A) Left two panels: tubular
structures formed by mock and SOX18 transduced ASCs (phase contrast microscopy). Bars: 1000 μm. Right panel: total length of
tubular structures was analyzed as described in Materials and methods. Data are represented as mean and SD of 3 ASC isolates
(*p b 0.05). (B) Individual tubular structure, Z-intervals of 48 μm, upper row: differential interference contrast (DIC) microscopy,
simultaneously, and in the same Z-plane, GFP signal of SOX18-transduced cells was recorded (lower row). Arrows indicate GFP
fluorescence signal colocalizing with DIC signals. Bars: 50 μm. (C) After fixation, fibrin matrices were embedded in paraffin and
sectioned at 5 μm thickness, perpendicular to the surface of the matrix, and stained for CD34 and VEGFR2 (brown/red). m: mock
transduced ASCs, s: SOX18 transduced ASCs. Arrows indicate ingrowing cells that show positive staining. (D) Upper panel: hematoxilin
stain, boxed individual vascular structure was recorded in more detail at 5-fold higher magnification (1000×). Lower panel: electron
microscopy of SOX18 transduced ASCs in a fibrin matrix. Magnification 3400×, bar: 5 μm.
374 R.D. Fontijn et al.endothelial markers as PECAM1 (CD31) (Miranville et al.,
2004), Tie2 (Konno et al., 2010), KDR and CD34 (Wosnitza et
al., 2007; Konno et al., 2010). Reprogramming of fibroblasts to
pluripotency, or direct conversion of fibroblasts to differen-
tiated, functional cells, is based on transfer of specific sets of
transcription factors (Takahashi & Yamanaka, 2006;
Vierbuchen et al., 2010; Ieda et al., 2010). Human neonatal
fibroblasts were transdifferentiated to endothelial cells,
applying transduction of the induced pluripotent stem
cell-factors Oct4 and Klf4 under inductive signaling conditions
(Li et al., 2013). Here, we report on an approach that aims atcontrolled in vitro induction of endothelial features in ASCs by
combining optimized culture conditions described by Konno et
al. (2010) with direct reprogramming of the cells using SOX18,
an endothelial-specific transcription factor that plays a
key role in endothelial differentiation and development of
the vasculature (François et al., 2010).
We could confirm that under the growth conditions applied,
human ASCs show expression of the endothelial markers CDH5,
PECAM1 and TIE2 at low levels (b0.4%) compared to primary
endothelial cells. Additional transduction of ASCs with SOX18
tended to further increase expression of these genes, however,
Figure 6 Effects of MMP- and VEGF-inhibition on formation of tubular structures in 3D matrices by SOX18-transduced ASCs. ASCs
were grown and transduced with mock or SOX18 lentivirus as described in Materials and methods. One day after transduction, cells
were seeded on preformed matrices and grown in the presence or absence of inhibitors as described in Materials and methods. After
3 days the clots were fixed with 2% paraformaldehyde. (A) MMP inhibition with 5 μg/ml (w/v) Batimastat. Left two panels: tubular
structures were recorded using phase contrast microscopy. Bars: 1000 μm. Right panel: total length of tubular structures was
quantified as described in Materials and methods. Data are represented as mean and SD of 3 ASC isolates (*p b 0.05). (B) VEGF
inhibition with 200 μg/ml (w/v) Avastin. Left two panels: tubular structures were recorded using phase contrast microscopy. Bars:
1000 μm. Right panel: total length of tubular structures was quantified as described in Materials and methods. Data are represented
as mean and SD of 3 ASC isolates (*p b 0.05).
375Adipose tissue-derived stromal cells acquire endothelial-like features upon reprogrammingthis increase did not reach significant levels. CLDN5, a gene
encoding the endothelial-specific tight junction protein claudin
5 and earlier described by our group as a direct target gene of
SOX18 in HUVEC (Fontijn et al., 2008), showed significant
upregulation upon SOX18 transduction in ASCs. Final mRNA
levels amounted to a fraction of the levels observed in HUVEC
and the protein could not be detected using immunofluores-
cence. In contrast, we found that SOX18 transduction specifi-
cally induced high expression levels of CD34 and KDR. Apart
from their function in vasculogenesis and angiogenesis, KDR
and CD34 are considered markers that occur in endothelial
differentiation as early as the hemangioblast-stage. Their
appearance, upon SOX18 transduction, together with the
vascular patterning genes MMP7, EFNB2, SEMA3G and CXCR4,
shows that in ASCs, ectopic expression of SOX18 is sufficient to
induce a subset of genes involved in endothelial differentia-
tion and vasculogenesis. The limited expression of markers of
mature endothelial cells indicates that for further endothelial
differentiation additional transcriptional programming, com-
plementary to SOX18, is required. Here, it should be noted
that in our experiments, SOX18 was constitutively expressed
from a viral promoter, rather than from the native promoter
which is likely subject to regulatory mechanisms.
In vivo, the function of SOX18 in endothelial differenti-
ation and vascular development has proven difficult to
dissect, due to the redundant function of members of theSOXF subfamily: SOX18, SOX17 and SOX7. Vascular anomalies
observed in different animal models, including the naturally
occurring ragged allelicmutants inmouse (Pennisi et al., 2000a;
Downes et al., 2009), SOX18-null mouse (Pennisi et al., 2000b;
François et al., 2008) and subsequent combined SoxF knock outs
in mouse and zebra fish (Sakamoto et al., 2007; Herpers et al.,
2008; Pendeville et al., 2008; Cermenati et al., 2008; Matsui et
al., 2006; Sacilotto et al., 2013) point at the crucial roles of
SOX18 in endothelial differentiation, arteriovenous specifica-
tion, lymphangiogenesis andmaintenance of vascular structural
integrity. Young et al. (Young et al., 2006) studied the role of
SOX18 in angiogenesis in an in vitro tube formation assay using
endothelial cells. Overexpression of wild type SOX18 and the
dominant negative SOX18 RaOp mutant resulted in gain and
loss of tube formation, respectively. These studies reveal that
correct spatiotemporal SOX18 expression is essential in several
stages of vascular development.
In the experiments described in this report, molecular
and cellular processes downstream of SOX18 were studied in
a non-endothelial background. Effects of SOX18 expression
on ASCs were manifested in an endothelial-like cell
morphology and responsiveness to forces exerted by laminar
flow. SOX18 induced responsiveness of ASCs to VEGF in a
chemotaxis assay and rendered ASCs the capacity to enter
3D matrices of different compositions, migrate and form
multicellular structures that reveal extensive intracellular
376 R.D. Fontijn et al.vacuolation, a process known to be an important component
of luminogenesis in many vascular beds (Sacharidou et al.,
2012).
Consistent with findings by Hoeth et al. in HUVEC (Hoeth
et al., 2012), we observed that in ASCs, SOX18 modulates
the expression of a repertoire of patterning genes, including
MMP7. In addition, we found induction of KDR (VEGFR2), a
morphogen receptor crucial in both vasculogenesis and
angiogenesis (Carmeliet et al., 1996). Using the MMP inhibitor
Batimastat, we could show that MMP activity is obligatory for
formation of tubular structures and found that among the
MMPs tested, only MMP7 showed significant upregulation upon
SOX18 overexpression. Therefore, it seems likely that, in
our model, MMP7 is essential for matrix degradation and thus
a prerequisite for tube formation. MMP7 may efficiently
degrade a broad range of extracellular matrix proteins,
including fibrin and may regulate angiogenesis by activa-
tion, degradation and shedding of non-ECM proteins (Binni
et al., 1999; Miyazaka et al., 1990; Ii et al., 2006). Inhibition
of VEGF, using Avastin, or KDR kinase activity, using SU1498,
did not affect tube formation, suggesting that the contri-
bution of VEGF-dependent processes to tube formation is
relatively small. Nevertheless, SOX18 transduced cells were
capable of VEGF-dependent chemotaxis as shown in a transmi-
gration assay. Interestingly, other guiding molecules, like
SEMA3G and EFNB2 were induced, in addition to CD34 and
CXCR4. Based on their function, these SOX18 target genes
are plausible SOX18-effector molecules in our in vitro tube
forming assay as well as in in vivo vasculogenic processes found
to be directed by SOX18 in studies using reverse genetics
(Sakamoto et al., 2007; Herpers et al., 2008; Pendeville et al.,
2008; Cermenati et al., 2008; Matsui et al., 2006; Sacilotto et
al., 2013). Sema3G was found to be associated with endothelial
cells of the angiogenic arterial vasculature and showed binding
to neuropilin receptors 1 and 2 (Kutschera et al., 2011).
Mechanistically, the role of class 3 semaphorins in angiogenesis
is poorly understood. Semaphorins may compete with VEGF for
neuropilin binding and thus inhibit angiogenesis (Neufeld et al.,
2012). In contrast, autocrine class 3 semaphorins may provide
highly localized signals that antagonize endothelial integrin
activation and thus enhance angiogenic plasticity (Serini et al.,
2003). Ephrin-B2 is essential for proper vascular develop-
ment during embryogenesis and was shown to be involved
in arteriovenous specification (Adams et al., 1999; Gerety et
al., 1999; Wang et al., 1998; Füller et al., 2003). Interestingly,
in SOXF mutant zebra fish this arteriovenous specification
is disturbed (Herpers et al., 2008; Pendeville et al., 2008;
Cermenati et al., 2008). Furthermore, Ephrin-B2 contributes
to sprouting angiogenesis and endothelial cell assembly by
modulation of VEGR2 and VEGFR3 signaling (Sawamiphak et
al., 2010; Wang et al., 2010). Taken together, the observed
effects of SOX18 transduction on ASCs are consistent with
findings in SOX18 animal models and point at controlled
induction of some endothelial-like features that, at least in
part, can be accounted for by induction of a specific set of
SOX18-downstream genes.
Thus, our in vitro findings provide support for the
hypothesis that ASCs acquire endothelial-like features upon
reprogramming with SOX18. However, given the observed
limited expression of endothelial-specific markers, additional
factors will have to be defined to enhance ASC-endothelial
transdifferentiation and proceed to in vivo studies. Inconclusion, this in vitro study identifies SOX18 as a novel,
promising factor for use in reprogramming strategies aimed
at conversion of ASCs to endothelial cells for use in cardio-
vascular regenerative medicine.
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